Lilly’s new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

Posted by | May 10, 2019 | |

By Julie Steenhuysen INDIANAPOLIS (Reuters) – Eli Lilly and Co has pulled ahead in a...

Read More